Morning Briefing
Summaries of health policy coverage from major news organizations
Drug Companies' Desires To Maintain Status Quo Are 'Lethal'
In the second of a two-part Al Jazeera opinion-piece series "examining the methods by which multinational drug corporations inflate their expenses and justify their pricing strategies," Khadija Sharife, a journalist and visiting scholar at the Center for Civil Society, looks at U.S. tax laws, lax oversight of international clinical trials, the cost of research on new pharmaceutical compounds, and vaccine manufacturing.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
